更新　平成30年10月2日

 

日本保健物理学会
会員の皆様

 

　当学会共催「ICRP-QST-RERF Workshop on Individual Response to Ionising Radiation」のFirst Announcementが届きましたのでお知らせ致します。

 

http://www.icrp.org/docs/ICRP-QST-RERF%20Workshop%20Dec%202018%20First%20Announcement.pdf

 

First Announcement

ICRP-QST-RERF Workshop on Individual Response to Ionising Radiation

Current Scientific Evidence on Factors that Influence Individual Response

National Cancer Center Japan， Research Institute， Tokyo 12 December， 2018

 

Organised by the International Commission on Radiological Protection (ICRP)，
National Institutes for Quantum and Radiological Science and Technology (QST) and
Radiation Effect Research Foundation (RERF)

 

In collaboration with National Cancer Center Japan (NCC)， Japanese Society for Radiation Oncology (JASTRO)， Japan Radiological Society (JRS)， Japan Health Physics Society (JHPS) and the Japanese Radiation Research Society (JRRS)

 

Registration

Attendance at the workshop is free of charge. However， advance registration is required as attendance is limited. Please send your name， affiliation， and e-mail address to Hiroki Fujita (ICRP Assistant Scientific Secretary) at register@icrp.org by 30 November 2018.

 

Symposium venue

Tsukiji Campus， National Cancer Center Japan， Research Institute， Tokyo， JAPAN
Access: https://www.ncc.go.jp/en/about/access/index.html

 

Preliminary program

 

09:00～09:30 Welcome and Greetings

09:30～17:00 Scientific Session

 

Speaker:
1. W. Ruhm (ICRP): Setting the Scene

2. A. Wojcik (ICRP): Human Individual Radiation Sensitivity and Prospects for Prediction 　　

　Factors

 

(10:30～11:00 Coffee break)

 

3. M. Bourgignon (ICRP): Radiosensitivity and radiotherapy patients

4. A. Brenner (RERF): Age-dependence of breast cancer risk

5. K. Ozasa (RERF): Life-style related cancer risk: Smoking and cancer

 

(12:30～13:00 Lunch break)

 

6. Y. Suto (QST/NIRS): Individual difference of chromosome aberration in accidentally 　

　exposed workers

7. H. Ohnishi (JASTRO): Individual difference of post irradiated antitumor effect and lung 　
　damage in patients with lung cancer

8. M. Akahane (JRS): Individual variation in clinical practices and protocols

 

(15:00 ～15:30 Coffee break)

 

9. Moderated Discussion

 

17:00 Closing

 

以上